SEARCH

SEARCH BY CITATION

References

  • 1
    Sarin SK, Kumar A, Chawla YK, Baijal SS, Dhiman RK, Jafri W, et al. Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment. Hepatol Int 2007;1:398-413.
  • 2
    Sarin SK, Sollano JD, Chawla YK, Amarapurkar D, Hamid S, Hashizume M, et al. Members of the APASL working party on portal hypertension. Consensus on extra-hepatic portal vein obstruction. Liver Int 2006;26:512-519.
  • 3
    Sarin SK, Kumar A. Noncirrhotic portal hypertension. Clin Liver Dis 2006;10:627-651.
  • 4
    Schouten JNL, Garcia-Pagan JC, Valla DC, Janssen HL. Idiopathic noncirrhotic portal hypertension. Hepatology 2011;54:1071-1081.
  • 5
    Sato Y, Nakanuma Y. Role of endothelial-mesenchymal transition in idiopathic portal hypertension. Histol Histopathol 2013;28:145-154.
  • 6
    Khanna R, Sarin SK. Non-cirrhotic portal hypertension—diagnosis and management. J Hepatol 2014;60:421-441.
  • 7
    Kapoor S, Pal S, Sahni P, Chattopadhyay TK. Thromboelastographic evaluation of coagulation in patients with extrahepatic portal vein thrombosis and non-cirrhotic portal fibrosis: a pilot study. J Gastroenterol Hepatol 2009;24:992-997.
  • 8
    Dhiman RK, Chawla Y, Vasishta RK, Kakkar N, Dilawari JB, Trehan MS, et al. Non-cirrhotic portal fibrosis (idiopathic portal hypertension): experience with 151 patients and a review of the literature. J Gastroenterol Hepatol 2002;17:6-16.
  • 9
    Chakraborty D, Sunil HV, Mittal BR, Bhattacharya A, Singh B, Chawla Y. Role of Tc99m sulfur colloid scintigraphy in differentiating non-cirrhotic portal fibrosis from cirrhosis liverRole of Tc99m sulfur colloid scintigraphy in differentiating non cirrhotic portal fibrosis from cirrhosis liver. Indian J Nucl Med 2010;25:139-142.
  • 10
    Furuichi Y, Moriyasu F, Taira J, Sugimoto K, Sano T, Ichimura S, et al. Noninvasive diagnostic method for idiopathic portal hypertension based on measurements of liver and spleen stiffness by ARFI elastography. J Gastroenterol 2013;48:1061-1068.
  • 11
    Siramolpiwat S, Seijo S, Miquel R, Berzigotti A, Garcia-Criado A, Darnell A, et al. Idiopathic portal hypertension: natural history and long-term outcome. Hepatology 2013. doi: 10.1002/hep.26904.
  • 12
    Nayak NC, Jain D, Vasdev N, Gulwani H, Saigal S, Soin A. Etiologic types of end-stage chronic liver disease in adults: analysis of prevalence and their temporal changes from a study on native liver explants. Eur J Gastroenterol Hepatol 2012;24:1199-1208.
  • 13
    Saigal S, Nayak NC, Jain D, Kumaran V, Mohanka R, Saraf N, et al. Non-cirrhotic portal fibrosis related end stage liver disease in adults: evaluation from a study on living donor liver transplant recipients. Hepatol Int 2011;5:882-889.
  • 14
    Sarin SK, Gupta N, Jha SK, Agrawal A, Mishra SR, Sharma BC, et al. Equal efficacy of endoscopic variceal ligation and propranolol in preventing variceal bleeding in patients with noncirrhotic portal hypertension. Gastroenterology 2010;139:1238-1245.
  • 15
    Chawla Y, Duseja A, Dhiman RK. Review article: the modern management of portal vein thrombosis. Aliment Pharmacol Ther 2009;30:881-894.
  • 16
    Sharma BC, Singh RP Chawla YK, Narasimhan KL, Rao KL, Mitra SK. Effect of shunt surgery on spleen size, portal pressure and esophageal varices in non cirrhotic portal fibrosis. J Gastroenterol Hepatol 1997;12:582-584.
  • 17
    Rajalingam R, Javed A, Sharma D, Sakhuja P, Singh S, Nag HH, et al. Management of hypersplenism in non cirrhotic portal hypertension: a surgical series. Hepatobiliary Pancreat Dis Int 2012;11:165-171.